{
  "ptid_time": "041_S_4513_2019-11-05",
  "img_path": "/data/qiuhui/data/adni/images/041_S_4513/2019-11-05/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 49,076 mm³, 63.4% above the reference mean. With a Z-score of 1.51 (93.4th percentile), this represents moderate enlargement; hippocampal volume measures 6,181 mm³, 23.0% below the reference mean. With a Z-score of -2.30 (1.1th percentile), this represents significant atrophy; whole brain volume measures 994,700 mm³, 12.3% below the reference mean. With a Z-score of -1.74 (4.1th percentile), this represents moderate atrophy; entorhinal cortex volume measures 3,648 mm³, 14.4% below the reference mean. With a Z-score of -1.00 (15.9th percentile), this represents normal volume ; fusiform gyrus volume measures 20,775 mm³, 4.4% above the reference mean. With a Z-score of 0.36 (64.1th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,037 mm³, 19.5% below the reference mean. With a Z-score of -1.61 (5.4th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 68.1 years. Gender is Male. Education: 19 years. MMSE: 30.0. MoCA: 30.0. Logical Memory: 14.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.15 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data show significant hippocampal atrophy (Z-score -2.30, 1.1th percentile) and moderate whole-brain atrophy (Z-score -1.74, 4.1th percentile), which are strong indicators of neurodegeneration. However, cognitive scores (MMSE 30, MoCA 30) are intact, and amyloid PET (AV45) is normal, suggesting no current clinical impairment despite structural changes.  \n\n**Diagnosis:** **MCI** (structural changes without cognitive decline)  \n**Confidence:** **Medium** (high confidence in neurodegeneration, but unclear if this will progress to dementia given normal amyloid and intact cognition)",
  "timestamp": "2025-07-26T07:19:09.915240"
}